Pierre Ernst

TL;DR: The TORCH and UPLIFT randomised controlled trials have provided important data on the benefits of COPD treatments, but also some lessons in study design and data analysis that suggest that long-acting bronchodilators, including anticholinergics and beta-agonists, are associated with lower mortality of patients with COPD, but not inhaled corticosteroids.

TL;DR: A conclusive association between the establishment of an asthma education centre and changes in health care use or the quality of prescribing could not be demonstrated.

TL;DR: In this article, the authors conducted a mailed survey of randomly selected Quebec physicians to identify key enablers of physician prescription of a long-term controller in patients with persistent asthma, and found that most physicians would prescribe a longterm controller (predominantly inhaled corticosteroids, ICS) to the patient in their clinical vignette.

TL;DR: In this paper, the rate of hospitalization for community-acquired pneumonia (HCAP) with SGLT-2i compared to DPP-4 inhibitors (DPP-4i) among patients with type 2 diabetes was compared.

TL;DR: In this article , the authors present the current state of evidence for long COVID syndrome, including the global public health context, incidence, prevalence, cardiopulmonary sequelae, physical and mental symptoms, recovery time, prognosis, risk factors, rehospitalization rates, and the impact of vaccination on long-COVID outcomes.